The preclinical studies indicated that suppression of hepatic Angptl3 protein production in mice resulted in reduced liver triglyceride content, enhanced insulin sensitivity, and limited atherosclerosis progression [63]. Here, ANGPTL3 is linked to atherosclerosis.